Universe Pharmaceuticals (UPC) Debt to Equity (2021 - 2025)
Universe Pharmaceuticals (UPC) has disclosed Debt to Equity for 5 consecutive years, with $0.04 as the latest value for Q3 2025.
- Quarterly Debt to Equity fell 78.63% to $0.04 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $0.04 through Sep 2025, down 78.63% year-over-year, with the annual reading at $0.04 for FY2025, 78.63% down from the prior year.
- Debt to Equity hit $0.04 in Q3 2025 for Universe Pharmaceuticals, down from $0.18 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.18 in Q3 2024 to a low of $0.0 in Q3 2022.
- Historically, Debt to Equity has averaged $0.04 across 5 years, with a median of $0.0 in 2021.
- Biggest five-year swings in Debt to Equity: soared 89530.22% in 2024 and later crashed 78.63% in 2025.
- Year by year, Debt to Equity stood at $0.0 in 2021, then crashed by 77.21% to $0.0 in 2022, then skyrocketed by 104.93% to $0.0 in 2023, then skyrocketed by 89530.22% to $0.18 in 2024, then plummeted by 78.63% to $0.04 in 2025.
- Business Quant data shows Debt to Equity for UPC at $0.04 in Q3 2025, $0.18 in Q3 2024, and $0.0 in Q3 2023.